MetaCap

Taysha Gene Therapies (TSHA) News

NASDAQ: TSHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.72-0.05 (-1.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TSHA news summary

We found 7 recent headlines mentioning Taysha Gene Therapies (TSHA): 0 in the past week and 7 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, TSHA is down 1.33% at $3.72. The most recent story, "Taysha Q3 Loss Widens On Higher Expenses; REVEAL 6-Month Interim Data Due In H1'27", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Taysha Gene Therapies headlines

Stocks mentioned alongside TSHA

Compare TSHA